Evidence map›Paper›PMID 34448959›Full record

ArticleCell biology and toxicology2023

Neuroprotective properties of queen bee acid by autophagy induction.

Guadalupe Martínez-Chacón, Marta Paredes-Barquero, Sokhna M S Yakhine-Diop, Elisabet Uribe-Carretero, Ariadna Bargiela, María Sabater-Arcis, José Morales-García, Jesús Alarcón-Gil, Eva Alegre-Cortés, Saray Canales-Cortés and 8 more

Abstract read
In one paragraph

Article in Cell biology and toxicology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. The critical role of Sirt1 in ischemic stroke.Frontiers in pharmacology · 2025
    Review
  6. Article
  7. In vitro anti-Archives of Razi Institute · 2024
    Article
  8. Article
  9. Dietary pattern and hepatic lipid metabolism.Liver research (Beijing, China) · 2023
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Guadalupe Martínez-ChacónDepartamento de Bioquímica y Biología Molecular y Genética, Facultad de Enfermería y Terapia Ocupacional, Universidad de Extremadura, Avda de la Universidad s/n, 10003, Cáceres, Spain.ORCID https://orcid.org/0000-0002-6301-8828
Marta Paredes-BarqueroDepartamento de Bioquímica y Biología Molecular y Genética, Facultad de Enfermería y Terapia Ocupacional, Universidad de Extremadura, Avda de la Universidad s/n, 10003, Cáceres, Spain.ORCID https://orcid.org/0000-0002-5698-8180
Sokhna M S Yakhine-DiopDepartamento de Bioquímica y Biología Molecular y Genética, Facultad de Enfermería y Terapia Ocupacional, Universidad de Extremadura, Avda de la Universidad s/n, 10003, Cáceres, Spain.
Elisabet Uribe-CarreteroDepartamento de Bioquímica y Biología Molecular y Genética, Facultad de Enfermería y Terapia Ocupacional, Universidad de Extremadura, Avda de la Universidad s/n, 10003, Cáceres, Spain.
Ariadna BargielaTranslational Genomics Group, Incliva Health Research Institute, Valencia, Spain.
María Sabater-ArcisTranslational Genomics Group, Incliva Health Research Institute, Valencia, Spain.
José Morales-GarcíaCentro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
Jesús Alarcón-GilInstituto de Investigaciones Biomédicas (CSIC-UAM) "Alberto Sols" (CSIC-UAM), Madrid, Spain.
Eva Alegre-CortésDepartamento de Bioquímica y Biología Molecular y Genética, Facultad de Enfermería y Terapia Ocupacional, Universidad de Extremadura, Avda de la Universidad s/n, 10003, Cáceres, Spain.
Saray Canales-CortésDepartamento de Bioquímica y Biología Molecular y Genética, Facultad de Enfermería y Terapia Ocupacional, Universidad de Extremadura, Avda de la Universidad s/n, 10003, Cáceres, Spain.
Mario Rodríguez-ArribasDepartamento de Bioquímica y Biología Molecular y Genética, Facultad de Enfermería y Terapia Ocupacional, Universidad de Extremadura, Avda de la Universidad s/n, 10003, Cáceres, Spain.
Pedro Javier CamelloDepartamento de Fisiología, Facultad de Veterinaria, Universidad de Extremadura, Cáceres, Spain.
José Manuel Bravo-San PedroCentro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
Ana Perez-CastilloCentro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
Rubén ArteroTranslational Genomics Group, Incliva Health Research Institute, Valencia, Spain.
Rosa A Gonzalez-PoloDepartamento de Bioquímica y Biología Molecular y Genética, Facultad de Enfermería y Terapia Ocupacional, Universidad de Extremadura, Avda de la Universidad s/n, 10003, Cáceres, Spain. rosapolo@unex.es.ORCID https://orcid.org/0000-0002-0163-2953
José M FuentesDepartamento de Bioquímica y Biología Molecular y Genética, Facultad de Enfermería y Terapia Ocupacional, Universidad de Extremadura, Avda de la Universidad s/n, 10003, Cáceres, Spain. jfuentes@unex.es.ORCID https://orcid.org/0000-0001-6910-2089
Mireia Niso-SantanoDepartamento de Bioquímica y Biología Molecular y Genética, Facultad de Enfermería y Terapia Ocupacional, Universidad de Extremadura, Avda de la Universidad s/n, 10003, Cáceres, Spain. mnisosan@unex.es.ORCID http://orcid.org/0000-0002-6506-422X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autophagy is a conserved intracellular catabolic pathway that removes cytoplasmic components to contribute to neuronal homeostasis. Accumulating evidence has increasingly shown that the induction of autophagy improves neuronal health and extends longevity in several animal models. Therefore, there is a great interest in the identification of effective autophagy enhancers with potential nutraceutical or pharmaceutical properties to ameliorate age-related diseases, such as neurodegenerative disorders, and/or promote longevity. Queen bee acid (QBA, 10-hydroxy-2-decenoic acid) is the major fatty acid component of, and is found exclusively in, royal jelly, which has beneficial properties for human health. It is reported that QBA has antitumor, anti-inflammatory, and antibacterial activities and promotes neurogenesis and neuronal health; however, the mechanism by which QBA exerts these effects has not been fully elucidated. The present study investigated the role of the autophagic process in the protective effect of QBA. We found that QBA is a novel autophagy inducer that triggers autophagy in various neuronal cell lines and mouse and fly models. The beclin-1 (BECN1) and mTOR pathways participate in the regulation of QBA-induced autophagy. Moreover, our results showed that QBA stimulates sirtuin 1 (SIRT1), which promotes autophagy by the deacetylation of critical ATG proteins. Finally, QBA-mediated autophagy promotes neuroprotection in Parkinson's disease in vitro and in a mouse model and extends the lifespan of Drosophila melanogaster. This study provides detailed evidences showing that autophagy induction plays a critical role in the beneficial health effects of QBA.

Indexed as

Neuroprotective AgentsParkinson DiseaseAnimalsAutophagyBeesCell LineDrosophila melanogasterHumansMiceNeuroprotectionNeuroprotective AgentsAutophagyLongevityNeurodegenerationParkinson’s diseaseQBASIRT1

Identifiers

PMID34448959
PMCPMC10406658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.